ライフサイエンスコーパス: Neuropsychiatric Inventory

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 tric symptoms and behaviours measured by the Neuropsychiatric Inventory.

2 detailed neuropsychological testing, and the Neuropsychiatric Inventory.

3 Behavioral changes were assessed with the Neuropsychiatric Inventory.

4 ychiatric symptoms were assessed through The Neuropsychiatric Inventory.

5 Frontal Behavioural Inventory (22%) and the Neuropsychiatric Inventory (28%) -- suggesting that thes

6 ychiatric examinations and were rated on the Neuropsychiatric Inventory, a widely used method for asc

7 hallucinations and agitation domains of the Neuropsychiatric Inventory) and extrapyramidal side effe

8 Behavioral changes were assessed with the Neuropsychiatric Inventory, and alterations in caregiver

9 hange Plus Caregiver Input (CIBIC-Plus), the Neuropsychiatric Inventory, and the Behavioral Rating Sc

10 ores for the Neuropsychiatric Inventory, the Neuropsychiatric Inventory Caregiver Distress Scale, or

11 s in caregiver distress were measured by the Neuropsychiatric Inventory distress scale.

12 ehavioural abnormalities, as measured by the Neuropsychiatric Inventory, in 148 patients with dementi

13 ry end point was change from baseline on the Neuropsychiatric Inventory (NPI) Agitation/Aggression do

14 ations between the 12 symptom domains in the Neuropsychiatric Inventory (NPI) and relapse in the firs

15 Mansfield Agitation Inventory (CMAI) and the Neuropsychiatric Inventory (NPI), ability to complete ac

16 neuropsychiatric symptoms as measured by the neuropsychiatric inventory (NPI).

17 sychiatric symptoms were evaluated using the Neuropsychiatric Inventory (NPI).

18 chiatric assessment was undertaken using the Neuropsychiatric Inventory (NPI).

19 opsychiatric symptom domains assessed by the Neuropsychiatric Inventory (NPI).

20 A total of 824 individuals completed the Neuropsychiatric Inventory (NPI); 362 were classified as

21 opsychiatric outcomes were measured with the Neuropsychiatric Inventory (NPI, 0-120 points) and the A

22 ons, and Delusions items (Core Total) of the Neuropsychiatric Inventory-Nursing Home version.

23 in Mini-Mental State Examination (P =.22) or Neuropsychiatric Inventory (P =.32) ratings over time.

24 Baseline Neuropsychiatric Inventory Questionnaire data were avail

25 Neuropsychiatric Inventory Questionnaire score.

26 ymptom (NOSYMP; n = 106) groups based on the Neuropsychiatric Inventory Questionnaire.

27 the Hamilton Depression Rating Scale and the Neuropsychiatric Inventory Questionnaire.

28 to frequency of behavioural symptoms on the Neuropsychiatric Inventory-Questionnaire and severity of

29 es indicated that depressive symptoms on the Neuropsychiatric Inventory-Questionnaire were less commo

30 Alzheimer's disease, were evaluated with the Neuropsychiatric Inventory-Questionnaire, the 15-item Ge

31 Neuropsychiatric Inventory scores also indicated faster

32 Neuropsychiatric Inventory scores worsened with placebo,

33 mg/day of galantamine had no change in total Neuropsychiatric Inventory scores.

34 matic or symptomatic at baseline, had better Neuropsychiatric Inventory subscale scores than did pati

35 r in behavioural severity as measured by the Neuropsychiatric Inventory; supporting the original clas

36 acebo and donepezil groups in scores for the Neuropsychiatric Inventory, the Neuropsychiatric Invento

37 ical Dementia Rating scale sum-of-boxes, the Neuropsychiatric Inventory, the Quality of Life-AD, and

38 es in Dementia (to assess function), and the Neuropsychiatric Inventory (to assess behavioral and psy

39 vement with olanzapine or risperidone on the Neuropsychiatric Inventory total score, risperidone on t

40 Assessment by means of the neuropsychiatric inventory was made at baseline, and aga

41 urs from the brief questionnaire form of the Neuropsychiatric Inventory were assessed.

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。